Inicio > BIGG > Resultado de la búsqueda

    Resultados: 5

    Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): 20-valent pneumococcal conjugate vaccine (PCV20) use among adults aged 19–64 years with an immunocompromising condition, cerebrospinal fluid leak, or cochlear implant who previously received a 13-valent pneumococcal conjugate vaccine (PCV13)

    MMWR recomm. rep; 72 (3), 2023
    On October 19, 2022, the U.S. Advisory Committee on Immunization Practices (ACIP) recommended the use of either a dose of 20-valent pneumococcal conjugate vaccine (PCV20) or 23-valent pneumococcal polysaccharide vaccine (PPSV23) as previously recommended for adults who have received 13-valent pneumococca...
    Vacuna Neumocócica Conjugada Heptavalente/inmunología, Huésped Inmunocomprometido, Implantación Coclear, Pérdida de Líquido Cefalorraquídeo
    Texto completo

    COVID-19 rapid guideline: children and young people who are immunocompromised

    England. National Institute for Health and Care Excellence.
    The purpose of this guideline is to maximise the safety of children and young people who are immunocompromised during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources....
    Huésped Inmunocomprometido/inmunología, Infecciones por Coronavirus/inmunología, Neumonía Viral/inmunología, Betacoronavirus/inmunología, Infecciones por Coronavirus/prevención & control
    Texto completo

    Pneumonia: diagnosis and management of community and hospital acquired pneumonia in adults

    National Clinical Guideline Centre.
    The microbial causes of pneumonia vary according to its origin and the immune constitution of the patient. Pneumonia is classified into community-acquired pneumonia (CAP), hospital-acquired pneumonia (HAP) and pneumonia in the immunocompromised. The guideline development process is guided by its scope - ...
    Neumonía Bacteriana/terapia, Neumonía Bacteriana/diagnóstico, Antibacterianos/uso terapéutico, Neumonía Asociada a la Atención Médica/prevención & control, Huésped Inmunocomprometido/inmunología, Neumonía/clasificación
    Texto completo

    Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) of Pneumococcal Vaccines for Immunocompromised Children Aged 6 through 18 Years

    MMWR recomm. rep; 62 (25), 2013
    GRADE was used to evaluate 13-valent Pneumococcal Conjugate Vaccine (PCV13) for routine use among immunocompromised children aged 6 through 18 years. Evidence of benefits, harms, values and preferences, and cost-effectiveness were reviewed in accordance with GRADE methods.[1] The primary policy question...
    Vacunas Neumococicas/uso terapéutico, Huésped Inmunocomprometido, Infecciones Neumocócicas/inmunología, Anemia de Células Falciformes/inmunología, Infecciones por VIH/inmunología, Inmunogenicidad Vacunal
    Texto completo

    Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) for Pneumococcal Vaccines for Immunocompromised Adults

    MMWR recomm. rep; 61 (40), 2012
    GRADE was used to evaluate 13-valent Pneumococcal Conjugate Vaccine (PCV13) and 23-valent pneumococcal polysaccharide vaccine (PPSV23) for routine use among immunocompromised adults. Evidence of benefits, harms, values and preferences, and cost-effectiveness were reviewed in accordance with GRADE methods...
    Vacunas Neumococicas/uso terapéutico, Infecciones Neumocócicas/inmunología, Huésped Inmunocomprometido, Inmunogenicidad Vacunal
    Texto completo